SGLT2 Inhibitors in Type 2 Diabetes: Prevention, Protection and Personalization
Starting on:
Apr 27, 2026
Ending on:
Apr 27, 2026
Moderator(s):
Dr. Noah Murby
Consultant Physician
Dr. Vinesh Vaghela
Consultant Cardiologist
Dr. Sood Mohamed
Consultant Nephrologist
Dr. Mohsen Gaballa
Consultant Interventional Cardiologist
Prof. Elijah Ogola
Consultant Physician
Prof. Nancy Kunyiha
Consultant Endocrinologist
Dr. Khalida Soki
Consultant Nephrologist
Venue:
Serena Hotel
Max Credits:
5 Points

Provider:
Kenya Diabetes Study Group
Claim Points

SGLT2 Inhibitors in Type 2 Diabetes: Prevention, Protection and Personalization

Starting on:
Apr 27, 2026
Ending on:
Apr 27, 2026
Venue:
Serena Hotel

Description

The role of SGLT2 inhibitors in the management of Type 2 Diabetes

Objectives

The role of SGLT 2 Inhibitors in the management and treatment of Diabetes

Presenters

  1. Prof. Michael Bohm
    Professor of Cardiology
    ESC

Search For CPD Activity